Adenosine as a neuromodulator in neurological diseases
- 18 October 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 8 (1) , 2-7
- https://doi.org/10.1016/j.coph.2007.09.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitryProgress in Neurobiology, 2007
- Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout micePAIN®, 2007
- Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's diseaseProgress in Neurobiology, 2007
- Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampusNeuropharmacology, 2007
- Neurobiology of SchizophreniaNeuron, 2006
- Astrocyte Control of Synaptic Transmission and Neurovascular CouplingPhysiological Reviews, 2006
- Adenosine A1 receptors are crucial in keeping an epileptic focus localizedExperimental Neurology, 2006
- Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaNeuroscience Letters, 2006
- Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockadePurinergic Signalling, 2005